SCHEMBL19082087

SCHEMBL19082087

c1ccc(-c2c3ccccc3c(-c3ccc4sc5c(ccc6c7cc8ccccc8cc7sc65)c4c3)c3ccccc23)cc1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 8/20 0.42
ESR2 Q92731 7/20 0.42
LIMK1 P53667 2/20 0.37
CYP1A1 P04798 1/20 0.35
CYP1B1 Q16678 1/20 0.35
ALOX5 P09917 2/20 0.34
TNKS O95271 1/20 0.34
TNKS2 Q9H2K2 1/20 0.34
PIM1 P11309 1/20 0.33
PIM3 Q86V86 1/20 0.33
PIM2 Q9P1W9 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
F9 P00740 1/20 0.32
ALDH1A1 P00352 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
PTPN1 P18031 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19082226 0.96 ESR1 (0.39) ESR1ESR2LIMK1CYP1A1CYP1B1
SCHEMBL17246871 0.91 ESR1 (0.46) ESR1ESR2LIMK1ALOX5PIM3
SCHEMBL17247068 0.90 ESR1 (0.45) ESR1ESR2LIMK1ALOX5PIM3
SCHEMBL19082222 0.89 ESR1 (0.40) ESR1ESR2LIMK1CYP1A1CYP1B1
SCHEMBL19077585 0.89 MAPT (0.35) ESR1ESR2LIMK1ALOX5TNKS
SCHEMBL19082243 0.89 ESR1 (0.36) ESR1ESR2LIMK1CYP1A1CYP1B1
SCHEMBL17944974 0.89 ESR1 (0.42) ESR1ESR2LIMK1ALOX5PIM3
SCHEMBL17944561 0.88 TNKS (0.43) LIMK1ALOX5TNKSTNKS2PIM3
SCHEMBL19077404 0.88 TNKS (0.37) ESR1ESR2LIMK1CYP1A1CYP1B1
SCHEMBL17945289 0.87 LIMK1 (0.39) ESR1ESR2LIMK1CYP1A1CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ESR1 225/4885ESR2 542/4885LIMK1 440/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ESR1 225/4885ESR2 542/4885LIMK1 440/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.